[F-18]-FLUDEOXYGLUCOSE (FDG) INJECTION

Опис товару

About [F-18]-FLUDEOXYGLUCOSE (FDG) INJECTION

[F-18]-FLUDEOXYGLUCOSE (FDG) INJECTION is a radiopharmaceutical agent used in positron emission tomography (PET) imaging for the assessment of glucose metabolism in various tissues. It contains the active ingredient Fluorodeoxyglucose 18F, a radiolabeled glucose analog that accumulates in areas of high metabolic activity.

Key Benefits & Uses

• Assessment of glucose metabolism in cancer cells, allowing for the detection and monitoring of tumors.
• Diagnosis and evaluation of cardiovascular diseases, including coronary artery disease and myocardial viability.
• Assessment of brain function and metabolism in neurological disorders, such as Alzheimer's disease and stroke.

Active Ingredient & Action

Fluorodeoxyglucose 18F (FDG) is a glucose analog that is taken up by cells through facilitated diffusion. Once inside the cell, FDG is phosphorylated by hexokinase, but it is not further metabolized due to the absence of the 2-deoxy group. This results in the accumulation of FDG in areas of high glucose metabolism, allowing for the visualization of tumors, inflammatory lesions, and other areas of increased metabolic activity.

Important Notes

[F-18]-FLUDEOXYGLUCOSE (FDG) INJECTION should only be administered under the guidance of a qualified nuclear medicine physician. The product is a radioactive substance and should be handled with caution. Patients should be advised to avoid close contact with others and to follow proper disposal procedures for radioactive waste.